PMID: 11930520Apr 5, 2002Paper

Psychopharmacology in pregnancy

The Journal of Perinatal & Neonatal Nursing
N A Gjere

Abstract

Clinicians are confronted with challenging situations when working with women who are pregnant and have a co-existing mental illness. A risk benefit assessment is helpful when identifying possible care interventions. Psychopharmaceutical intervention is a consideration when nonpharmacological interventions are ineffective or inappropriate. Informed consent based on known and unknown risks to the mother and fetus should be obtained. Literature and case reports are contradictory and not conclusive about the risks of medications used for psychiatric illnesses. This article reviews the literature and provides clinical guidelines for antipsychotic medications, antidepressant medications, mood stabilizing medications, and antianxiety medications.

References

Feb 1, 1975·Archives of General Psychiatry·R O RiederH Blumenthal
May 15, 1976·American Journal of Obstetrics and Gynecology·L Milkovich, B J van den Berg
Jan 1, 1977·The Journal of Pediatrics·J L Rementería, K Bhatt
Feb 1, 1977·Teratology·C Rumeau-RouquetteG Huel
Jul 1, 1977·The American Journal of Psychiatry·M F Cleary
Oct 1, 1977·British Medical Journal·G GreenbergJ C Haskey
Jan 1, 1992·Psychosomatics·L R DicksonM C Hyatt
Mar 15, 1990·The American Journal of Cardiology·E ZalzsteinR M Freedom
Jan 1, 1989·The Journal of Pediatrics·L LaegreidN Conradi
Jan 17, 1987·British Medical Journal·J B Loudon
Jul 1, 1987·Neurology·L I Golbe
Apr 1, 1972·British Medical Journal·M Sim
Oct 1, 1974·The Journal of Pediatrics·D E Parkin
Mar 18, 1972·British Medical Journal·D L CrombieD Fleming
Apr 29, 1972·British Medical Journal·E V Kuenssberg, J D Knox
Mar 18, 1972·The Medical Journal of Australia·D Freeman
Nov 26, 1981·The New England Journal of Medicine·P C Rubin
Jan 1, 1984·Comprehensive Psychiatry·M J Edlund, T J Craig
Oct 13, 1983·The New England Journal of Medicine
Oct 4, 1984·The New England Journal of Medicine·P H Shiono, J L Mills
Nov 24, 1983·The New England Journal of Medicine·L RosenbergS Shapiro
Jan 1, 1983·Human Toxicology·J GoldingJ A Baldwin
Feb 1, 1995·Journal of Clinical Psychopharmacology·R I Shader, D J Greenblatt
Nov 1, 1994·Reproductive Toxicology·F Rosa
Jan 1, 1994·International Journal of Psychiatry in Medicine·H L Goldberg
Oct 1, 1993·The American Journal of Psychiatry·K L WisnerS B Wheeler
Feb 1, 1996·The American Journal of Psychiatry·M FinnertyL J Miller
Mar 1, 1996·The American Journal of Psychiatry·C B NemeroffB G Pollock
Sep 1, 1996·The American Journal of Psychiatry·K L WisnerR L Findling
Oct 3, 1996·The New England Journal of Medicine·C D ChambersK L Jones
Oct 3, 1996·The New England Journal of Medicine·E Robert
Feb 1, 1996·Journal of Clinical Psychopharmacology·L L Altshuler, V C Hendrick
Nov 1, 1996·American Journal of Obstetrics and Gynecology·B C BrostR B Newman
Jan 23, 1997·The New England Journal of Medicine·I NulmanG Koren
Apr 1, 1997·Seminars in Perinatology·K G Goldaber
May 1, 1997·Journal of Nurse-midwifery·C Clarke, L L Paine
Aug 1, 1997·The Journal of Clinical Psychiatry·S C StonerJ Vaughn
Aug 26, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·R A Dickson, L Hogg
Jun 6, 2000·Journal of Women's Health & Gender-based Medicine·L H Gold

❮ Previous
Next ❯

Citations

Dec 13, 2005·Journal of Psychiatric and Mental Health Nursing·K UsherP McNamara
Jun 19, 2004·Neurotoxicology and Teratology·Marcelo Javier WolanskyJulio Marcos Azcurra
Sep 4, 2015·Indian Journal of Psychiatry·Daya Ram, S Gandotra
Jan 23, 2002·Pharmacoepidemiology and Drug Safety

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Human Lactation : Official Journal of International Lactation Consultant Association
E A Winans
The Australian and New Zealand Journal of Psychiatry
M P Austin, P B Mitchell
Best Practice & Research. Clinical Obstetrics & Gynaecology
M Craig, K Abel
© 2022 Meta ULC. All rights reserved